Bobby Azamian, Co-founder, Chairman & CEO of Tarsus Pharmaceuticals—founded in 2016 and now a fast-growing leader in eyecare—shares how a singular focus on patient need led to a blockbuster therapy for over 25 million people. He discusses creating new categories in medicine, expanding into untapped “white spaces” like Lyme disease prevention, and building a culture defined by commitment, empowerment, and teamwork.
The interview was recorded on October 7, 2025.